5Kastan MB, Canman CE, Leonard C J, P53, cell-cycle control and apoptosis-implications for cancer. Cancer Metastasis Rev, 1995,14 ( 1 ) : 3 - 15,.
6Randrianarison V, Marot D, Foray N, et al. BRCA 1 carries tumor suppressor activity distinct from that of p53 and p21, Cancer Gene Ther, 2001,8(10) :759 -770.
7Alvarez RD, Gomez-Navarro J, Wang M, et al. Adenoviral-mediated suicide gene therapy for ovarian cancer. Mol Ther, 2000,2(5) : 524 - 530.
8Tai YT, Strobel T, Kufe D, et al. In vivo cytotoxicity of ovarian cancer cells through tumor-selective expression of the BAX gene. Cancer Res, 1999,59(9):2121 - 2126.
9Janicek MF, Sevin BU ,Nguyen HN, et al. Combination anti-gene therapy targeting c-myc and p53 in ovarian cancer cell lines. Genecol Oncol, 1995,59(1 ):87 - 92.
10Sabet MK,Funato T,Fodstad O,et al.Suppression of tile nepotistic in vivo by an anti-ras ribzyome.Cancer Res, 1994,54(4) :900 - 902.
